Wednesday, June 22, 2022 | |||
IEPA PRE-CONGRESS WORSKHOPS | |||
Time | HALL A | HALL B | |
9:00 | 11:00 | Workshop 1: Kate Hardy (USA): CBT for the early stages of psychosis (Group A) |
Workshop 2: Philippe Conus (Switzerland): Initial treatment for psychosis: What are the main targets, and how can we face the greatest challenges (Group A) |
11:00 | 13:00 | Workshop 3: Juliana Onwumere (United Kingdom): Supporting families and carers in the early phase of psychosis (Group A) |
Workshop 4: Marieke Begemann (The Netherlands): Managing antipsychotic discontinuation (Group A) |
13:00 | 14:00 | INTERMISSION | |
14:00 | 16:00 | Workshop 1: Kate Hardy (USA): CBT for the early stages of psychosis (Group B) |
Workshop 4: Marieke Begemann (The Netherlands): Managing antipsychotic discontinuation (Group B) |
16:00 | 18:00 | Workshop 3: Juliana Onwumere (United Kingdom): Supporting families and carers in the early phase of psychosis (Group B) |
Workshop 2: Philippe Conus (Switzerland): Initial treatment for psychosis: What are the main targets, and how can we face the greatest challenges (Group B) |
Thursday, June 23, 2022 | ||
Time | HALL A |
HALL B |
08:30-09:30 | REGISTRATION | |
09:30-10:30 | ORAL PRESENTATIONS SESSION 1 |
ORAL PRESENTATIONS SESSION 2 |
10:30-11:30 |
SYMPOSIUM 1: IEPA Symposium: Intervention strategies for supporting people in the early stages of psychosis Kate Hardy: Current state of the evidence for CBT for psychosis |
SYMPOSIUM 2: Early diagnosis of younger onset dementia in people with psychiatric presentations Yolande Pijnenberg (The Netherlands): Differentiating FTD from psychiatric presentations |
11:30-12:00 |
COFFEE BREAK | |
12:00-12:30 |
KEYNOTE LECTURE 1
Swaran P. Singh (United Kingdom): Early Intervention in low-resource settings: luxury or necessity? |
|
12:30-13:30 |
SYMPOSIUM 3: Early onset mood disorders: under-recognised and under-treated? Allan Young (United Kingdom): Slow train coming: The onset of Bipolar Disorder |
SYMPOSIUM 4: Discrete versus Continuum Models of Schizophrenia and Psychosis: Current Status and Future Directions
Laila Hasmi (The Netherlands): Can we really separate non-psychotic disorders from the Clinical High Risk for Psychosis phenotype? |
13:30-14:30 |
SPONSORED SYMPOSIUM 1 | |
14:30-15:30 |
SYMPOSIUM 5: Prevention and early detection of psychosis: where are we now? David Baron (United States): The role of primary care in identifying psychosis |
SYMPOSIUM 6: Stress and the continuum of disease development: A transdiagnostic target for primary, secondary and tertiary prevention George Chrousos (Greece): The origins of Stress: Philosophical and historical concepts |
15:30-16:00 |
COFFEE BREAK | |
16:00-16:30 | KEYNOTE LECTURE 2
Christoph Correll (Germany/ USA): What is the effectiveness of early intervention services for people with psychosis |
|
16:30-17:00 |
KEYNOTE LECTURE 3 Nikolaos Koutsouleris (Germany): Predictive data science in clinical application in mental health: where do we stand and where do we go from here? |
|
17:00-18:00 |
SYMPOSIUM 7: Psychoses in the Global South Thara Rangaswamy (India): INTREPID II: International Programme of Research on Psychoses in Diverse Settings |
SYMPOSIUM 8: Early detection and intervention in psychosis and clinical high risk states Inge Joa & Jone Bjørnestad (Norway): Early detection and intervention in Clinical High Risk for psychosis and symptom-level predictors of course |
18:00-18:30 | OPENING SESSION - WELCOME ADDRESSES |
Friday, June 24, 2022 | ||
Time | HALL A |
HALL B |
09:30-10:45 |
SYMPOSIUM 9: Novel evidence-based approaches to dementia prevention Dimitris N Kiosses (USA): Emotion regulation and problem-solving approaches to improve mood, functioning, and cognition in older adults with depression and cognitive deficits |
SYMPOSIUM 10: Neurodevelopmental disorders: Early detection and intervention in vulnerable groups, from the antenatal period to childhood and adult life Laura Pina-Camacho (Spain): The PremTEA Project. Early detection of neurodevelopmental disorders in extremely preterm newborns: a four year follow-up study |
10:45-11:00 | COFFEE BREAK |
|
11:00-11:30 | KEYNOTE LECTURE 4 Patrick McGorry (Australia): Early Intervention – Psychosis and Beyond |
|
11:30-12:30 |
SYMPOSIUM 11: Decreasing or stopping antipsychotics: a neglected topic? David Taylor (United Kingdom): Long-acting antipsychotic injections and treatment cessation |
SYMPOSIUM 12: Hearing and vision support as a means of early intervention for older adults with memory impairment Antonis Politis (Greece): Hearing and vision deficits associated behavioural and psychiatric disturbances in dementia: An opportunity for early intervention to avoid drug therapy? |
12:30-13:30 | SPONSORED SYMPOSIUM 2 | |
13:30-15:00 | ORAL PRESENTATIONS SESSION 4 | ORAL PRESENTATIONS SESSION 5 |
15:00-16:00 |
SYMPOSIUM 13: How do environmental and genetic risk factors shape the vulnerability for psychotic disorders? Marta Di Forti (United Kingdom): Cannabis-associated psychosis: Is it worth modifying the environment if genes have such an important role? |
|
16:00-16:30 | COFFEE BREAK | |
16:30-17:30 |
SYMPOSIUM 14: Ethics and personal meaning in patients with early onset psychosis Ilina Singh (United Kingdom): Valued Outcomes and Identified Drivers of Change among Participants in the England Early Intervention in Psychosis Programme |
SYMPOSIUM 15: Early intervention in neurodiverse children and adolescents Hassiotis Angela (United Kingdom): Evaluation of Parent Intervention for Challenging Behaviour in preschool children with severe intellectual disabilities (EPICC-ID): a randomised controlled trial |
17:30-18:00 | KEYNOTE LECTURE 5 Jim van Os (The Netherlands): Appreciating the complexity of psychosis as a target of prevention |
|
18:00-19:00 | SPONSORED SYMPOSIUM 3 |
Saturday, June 25, 2022 | ||
Time | HALL A |
HALL B |
09:00-10:00 |
SYMPOSIUM 16: ADHD: life-time continuity, serious mental illness, and genetics Luis Augusto Rohde (Brazil): What is new on ADHD trajectories? From new patterns to prediction |
SYMPOSIUM 17: Electrophysiological biomarkers and early intervention in neuropsychiatric disorders across the lifespan Bahar Güntekin (Turkey): Electrophysiological biomarkers of cognitive impairment in patients with Alzheimer disease: possible use in clinical trial |
10:00-10:30 | KEYNOTE LECTURE 6 John Kane (USA): The pharmacological treatment of schizophrenia: how far have we come? |
|
10:30-11:00 | KEYNOTE LECTURE 7 Petros Levounis (USA): Technological Addictions: The New Frontier in Addiction Psychiatry from Technology Natives to Technology Immigrants |
|
11:00-12:00 |
SYMPOSIUM 18: Early Intervention in Psychosis: From promise to delivery and beyond Silvana Galderisi (Italy): Negative symptoms in first-episode schizophrenia and in children/adolescents at ultra-high risk for psychosis |
SYMPOSIUM 19: Early intervention in bipolar disorders: problems and potential solutions Jan Scott (United Kingdom): Conceptualising and estimating duration of untreated bipolar disorders: a systematic review and meta-analysis of data from around the world |
12:00-12:30 | BREAK | |
12:30-13:00 | KEYNOTE LECTURE 8 Robin Murray (United Kingdom): A public health approach to the prevention of psychosis |
|
13:00-13:30 | SUM UP OPEN SESSION | |
13:30-13:45 | CLOSING SESSION
|